Bionano Genomics Inc.

NASDAQ: BNGO · Real-Time Price · USD
3.03
-0.18 (-5.61%)
At close: Aug 15, 2025, 2:52 PM

Bionano Genomics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-83.7M -112.02M -135.78M -204.1M -226.79M -232.49M -227.28M -146.52M -139.77M -132.6M -116.87M -105.81M -92.44M -72.44M -61.22M -51.26M -40.54M
Depreciation & Amortization
13.65M 14.23M 15.42M 13.42M 13.73M 13.91M 13.08M 11.84M 10.84M 9.84M 8.9M 7M 5.16M 3.37M 2.06M 1.85M 1.63M
Stock-Based Compensation
8.31M 9.74M 11.17M 12.96M 14.31M 15.18M 17.29M 19.35M 21.2M 22.42M 21.74M 18.47M 14.45M 9.72M 5.37M 3.03M 1.6M
Other Working Capital
-10.63M -5.59M -7.41M -4.86M -416K -6.33M -8.04M -3.54M -4.03M -3.96M -1.42M -788K 3.27M 1.99M 2.67M 2.73M -1.02M
Other Non-Cash Items
22.78M 23.57M 41.41M 19.91M 27.26M 27.39M 3.38M 3.35M 2.59M 2.35M 2.85M 2.35M 1.84M 1.48M 489.91K 995.91K 1.2M
Deferred Income Tax
n/a n/a -15.94M 61.26M 61.13M 61.13M 78.83M 1.63M 1.76M 1.76M -6.71M -6.71M -4.63M -6.41M 901.63K 945.63K -798.37K
Change in Working Capital
-868K 4.43M -4.08M -4.23M -6.14M -14.77M -15.21M -22.75M -21.36M -28.59M -25.84M -21.72M -14.9M -7.65M -6.01M -4.95M -7.27M
Operating Cash Flow
-43.55M -68.92M -96.72M -109.7M -125.42M -129.7M -129.92M -133.1M -124.73M -124.82M -115.92M -106.43M -90.52M -71.93M -58.41M -49.39M -44.19M
Capital Expenditures
-77K -103K -848K -923K -1.36M -1.69M -2.51M -2.72M -2.68M -3.3M -2.86M -2.83M -2.42M -1.46M 4.18M 4.58M 4.63M
Cash Acquisitions
n/a n/a 54.63M 21.13M 21.22M 21.22M -65.44M -31.25M -63.05M -62.36M -79.41M -80.1M -48.27M -48.96M 126.05K -2.32M -2.45M
Purchase of Investments
-187.23M -233.02M -321.1M -262.85M -221.92M -111.36M -25.57M -54.75M -69.24M -84.19M -171.27M -342.93M -328.35M -313.39M -205.33M n/a n/a
Sales Maturities Of Investments
199.5M 306.96M 337.42M 318.04M 278.3M 137.02M 150.37M 154.29M 170.6M 200.89M 201.87M 179.96M 133.66M 86.48M 20M n/a n/a
Other Investing Acitivies
n/a 47.61M -7.02M 26.49M 26.58M -21.03M 34.29M 96K 31.71M 31.74M 30.31M -154.33M -185.91M -185.94M -189.73M -6.98M -7.11M
Investing Cash Flow
12.19M 73.84M 15.47M 54.27M 55.22M 24.16M 91.14M 65.67M 67.33M 82.77M -21.35M -214.91M -246.07M -278.06M -185.55M -2.4M -2.47M
Debt Repayment
-16.76M -53.43M -60.43M -57.43M -45.71M -9.05M -44K -41K -38K -36K 1.98M 1.99M -15.01M -15.01M -17.01M -17.01M -1.23M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-6.71M -4.68M 62.34M 63.09M 65.14M 65.17M -890K -1.03M -457K -85K -241K -84K -444K 8.44M 16.56M 31.95M 31.64M
Financial Cash Flow
18.82M -13.69M 50.91M 57.48M 77.33M 113.81M 45.48M 55.54M 37.86M 23.01M 24.83M 15.94M -1.42M 336.11M 365.83M 367.15M 400.57M
Net Cash Flow
-12.53M -43.89M -25.77M 6.58M 11.65M 47.97M 6.8M -11.9M -19.54M -19.08M -112.57M -305.39M -338.01M -13.88M 121.87M 315.36M 353.91M
Free Cash Flow
-43.63M -69.03M -97.57M -110.63M -126.78M -131.39M -132.43M -135.82M -127.42M -128.12M -118.78M -109.27M -92.94M -73.39M -54.23M -44.81M -39.55M